All news

Glanbia falls 6% as Morgan Stanley cuts to underweight

Alpha Vantage · Yahoo Finance · · AI-summarised by FinFlash

Glanbia shares fell 6% after Morgan Stanley downgraded the Irish nutrition group to Underweight, citing intensifying competition and higher contracted whey costs. The bank cut its 12-month price target to €19.20, warning these factors could pressure 2027 margins and earnings. Morgan Stanley did raise its 2026 EPS estimate after Glanbia's Q3 beat.

Read original source

MS company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.